Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine developed to prevent coronavirus disease. Jointly created by the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca, it played a massive global role in the early stages of the pandemic, saving an estimated six million lives in its first year of use.
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine developed to prevent coronavirus disease. Jointly created by the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca, it played a massive global role in the early stages of the pandemic, saving an estimated six million lives in its first year of use.